References

  1. World Health Organisation. Global Tuberculosis Report 2014. Geneva, Switzerland: WHO. 2014. Google Scholar

  2. ONUSIDA. Fiche d’information 2015. Accessed on 20 April 2017

  3. Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012; 8(2): e1002464. PubMed | Google Scholar

  4. Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG et al, TBNET. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med. 2014 Nov 15; 190(10): 1168-76. PubMed | Google Scholar

  5. Matabane MMZ, Ismail F, Strydom AK, Onwuegbuna O, Omar SV, Ismail N. Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV burden setting. BMC Infect Dis. 2015; 15: 508. PubMed | Google Scholar

  6. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR et al. Evaluation of the analytical performance of the Xpert MTB/RIF Assay. J Clin Microbiol. 2010; 48(7): 2495-501. PubMed | Google Scholar

  7. Kaswa MK, Bisuta S, Kabuya G, Lunguya O, Ndongosieme A, Muyembe JJ et al. Multi Drug Resistant Tuberculosis in Mosango, a Rural Area in the Democratic Republic of Congo. PLoS One. 2014; 9(4): e94618. PubMed | Google Scholar

  8. Gounder A, Gounder S, Reid SA. Evaluation of the implementation of the Xpert® MTB/RIF assay in Fiji. Public Health Action. 2014; 4(3): 179-183. PubMed | Google Scholar

  9. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF Assay for rapid diagnosis of tuberculosis and detection of Rifampin Resistance in pulmonary and extra pulmonary specimens. J Clin Microbiol. 2011; 49(12): 4138-4141. PubMed | Google Scholar

  10. Sekadde MP, Wobudeya E, Joloba ML, Ssengooba W, Kisembo H, Bakeera-Kitaka S et al. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. BMC Infect Dis. 2013 Mar 12; 13: 133. PubMed | Google Scholar

  11. Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015 Oct 19; 15: 220. PubMed | Google Scholar

  12. Giang DC, Duong TN, Minh Ha DT, Nhan HT, Wolbers M, Nhu NT et al. Prospective evaluation of GeneXpert MTB/Rif for the diagnosis of HIV- negative pediatric TB cases. BMC Infect Dis. 2015; 15: 70. PubMed | Google Scholar

  13. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M et al. Screening for HIV-associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: a prospective Study. PLoS Med. 2011; 8(7): e1001067. PubMed | Google Scholar

  14. Carniel F, Dalla Costa ER, Lima-Bello G, Martins C, Scherer LC, Rossetti ML. Use of conventional PCR and smear microscopy to diagnose pulmonary tuberculosis in the Amazonian rainforest area. Braz J Med Biol Res. 2014; 47(12): 1016-20. PubMed | Google Scholar

  15. Hanrahan CF, Theron G, Bassett J, Dheda K, Scott L, Stevens W et al. Xpert MTB/RIF as a Measure of Sputum Bacillary Burden Variation by HIV Status and Immunosuppression. Am J Respir Crit Care Med. 2014; 189(11): 1426-34. PubMed | Google Scholar

  16. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014 Jan 21; (1): CD009593. PubMed | Google Scholar

  17. Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P et al. Detection of Drug-Resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med. 2015; 372(12): 1181-2. PubMed | Google Scholar